The Nippon India Pharma Fund is a specialized mutual fund managed by Nippon Life India Asset Management Limited. The fund focuses on investments in the pharmaceutical and healthcare sectors. It aims to provide you with opportunities for capital appreciation by strategically allocating your funds to pharmaceutical companies.
Guaranteed Tax Savings
Under sec 80C & 10(10D)₹1 Crore
Invest ₹10k per month*Zero LTCG Tax
Top performing plans with High Returns**
Invest ₹10K/month & Get ₹1 Crore returns*
Nippon India Pharma Fund is a sector-focused equity mutual fund that invests primarily in the shares of pharmaceutical and healthcare companies in India.
These businesses include pharmaceutical manufacturers, healthcare service providers, biotechnology companies, and related industries.
The investment objective of the fund is to generate long-term capital appreciation by investing in a diversified portfolio of companies across the pharmaceutical and healthcare sectors.
Particulars | Details |
Fund Name | Nippon India Pharma Fund |
Fund House | Nippon India Mutual Fund |
Launched On | 05 June 2004 |
Fund Size | Rs. 5539.19 Crores |
Benchmark Index | S&P BSE Healthcare TRI |
Risk Category | Very High |
Investment Objective | To achieve steady profits from investment in stocks, bonds, or related assets of pharmaceutical and affiliated companies. |
Fund Options |
|
Net Asset Value (NAV) |
|
Asset Allocation |
|
Market Cap Allocation |
|
Systematic Investment Plan (SIP) | Rs. 100 |
Minimum Lump sum Investment | Rs. 5000 (there onwards, Rs. 1000) |
Lock- in | NA |
Fund Manager |
|
Expense Ratio (as of 31 October 2023) |
|
Exit Load | 1% if you redeem in less than 1 year |
*All savings are provided by the insurer as per the IRDAI approved insurance plan. Standard T&C Apply
Name of Holdings | % of Total Holdings |
Top 5 Equity Holdings (96.08%) | |
Sun Pharmaceutical Industries Ltd. | 12.88% |
Lupin Ltd. | 7.75% |
Cipla Ltd. | 6.50% |
Dr. Reddys Laboratories Ltd. | 5.33% |
Apollo Hospitals Enterprises Ltd. | 4.47% |
Debt Holdings (3.92%) | |
TREPS | 4.04% |
Margin | 0.02% |
Net Receivables | - 0.14% |
Sector | % of Total Holdings |
Healthcare | 98.90% |
Others | 1.10% |
Investment Period | Annualised Returns (Direct) | Annualised Returns (Regular) |
1-Year | 32.53% | 29.48% |
3-Year | 18.82% | 17.39% |
5-Year | 20.51% | 19.50% |
10-Year | 18.22% | 16.93% |
Returns Since Inception (RSI) | 17.63% | 20.37% |
*Fund NAV as of 22 November 2023
To invest in Nippon India Pharma Fund, you generally need the following documents:
KYC Documents:
ID Proof (e.g., Aadhar card, driving license, passport)
Passport-size photographs
Address Proof(e.g., utility bill, passport, Aadhar card)
Bank Account Details
PAN Card
NRI/ OCI/ PIOs Documents
Valid Visa
Overseas Address Proof
NRE/ NRO Account Details
Valid NRI/ PIO Card
The key steps to start investing in Nippon India Pharma Fund are mentioned below:
Step 1- Research: Understand the Nippon India Pharma Fund's objectives and past performance.
Step 2- KYC Compliance: Complete the Know Your Customer (KYC) process with the required documents.
Step 3- Choose Platform: Select a reliable investment platform that offers the Nippon India Pharma Fund.
Step 4- Account Setup: Open an investment account on the chosen platform.
Step 5- Fund Selection: Locate Nippon India Pharma Fund and choose the investment amount.
Step 6- Transaction: Complete the investment transaction through the chosen platform.
Step 7- Monitor: Keep track of the fund's performance and adjust your investment strategy accordingly.
You can estimate the potential returns of your investment in Nippon India Pharma Fund through SIP by using the Policybazaar SIP calculator. A SIP calculator is a tool that helps you determine the future value of your investments based on the following factors:
Monthly SIP Amount: The amount you plan to invest each month.
Investment Horizon: The number of years you plan to invest.
Expected Rate of Return: The average annual return you expect to earn on your investments.
The calculator will provide an estimate of the potential future value of your investment.
Some of the most popular pharma mutual funds include:
Nippon India Pharma Fund
Tata India Pharma & Healthcare Fund
ICICI Prudential Pharma Healthcare & Diagnostics (PHD) Fund
Aditya Birla Sun Life Pharma & Healthcare Fund
Mirae Asset Healthcare Fund
Nippon India Pharma Fund – Regular Growth: Rs. 369.84
Nippon India Pharma Fund – Direct-Growth: Rs. 409.58
Nippon India Small Cap Fund
Nippon India Growth Fund
Nippon India Value Fund
*All savings are provided by the insurer as per the IRDAI approved insurance
plan.
*Tax benefit is subject to changes in tax laws. Standard T&C Apply
~Source - Google Review Rating available on:- http://bit.ly/3J20bXZ
†Policybazaar does not endorse, rate or recommend any particular insurer or insurance product offered by any insurer. This list of plans listed here comprise of insurance products offered by all the insurance partners of Policybazaar. The sorting is based on past 10 years’ fund performance (Fund Data Source: Value Research). For a complete list of insurers in India refer to the Insurance Regulatory and Development Authority of India website, www.irdai.gov.in
^^The information relating to mutual funds presented in this article is for educational purpose only and is not meant for sale. Investment is subject to market risks and the risk is borne by the investor. Please consult your financial advisor before planning your investments.